Delivery Order SPE2DB25D3108-SPE2DB25FPEBQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,587.03. This non-set-aside, competitively awarded delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.57 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $3,846.89. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,187.40 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg, with an ultimate completion date of September 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a contract ceiling value of $1,040.94. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Adderall XR 20 mg capsules. The contract has a ceiling value of $3,666.20 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a firm fixed price ceiling value of $1,891.02. The award, made on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and continues...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,057.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's broader pharmaceutical supply arrangement with the agency. The place of performance is the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count) with a ceiling value of $1,104.99 under a firm fixed-price contract type. The award, issued on May 1, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of May 2, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPEBQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,397.80. This award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, utilizes firm fixed price terms under a non-set-aside, competitively awarded contract. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications to support military and veteran healthcare systems. The company's federal contract history demonstrates consistent capability in delivering controlled substances and specialty pharmaceuticals through competitive acquisition, positioning it as a critical vendor within the DLA's global pharmaceutical support infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/26/25 |